Mr. Melnyk have 20,913,418 common shares as of todayTORONTO, June 21 2016 /CNW/ - Mr. Eugene Melnyk announced today that he sold 1,463,365 common shares of Acerus Pharmaceuticals Corporation (TSX: ASP) ("Acerus"), on June 9, 2016, through the facilities of the Toronto Stock Exchange. Between July 25, 2014 and June 9, 2016, Mr. Melnyk sold a total of 13,497,365 common shares at prices ranging from $0.08 to $0.62 per share for aggregate consideration of $3,431,427.28. Immediately after his June 9, 2016 sale, Mr. Melnyk owned 20,913,418 common shares, representing 9.8% of the outstanding common shares of Acerus. Immediately prior to that sale, he owned 22,376,783 common shares, representing 10.5% of the outstanding common shares.